Loading…

Cannabidiol promotes apoptosis via regulation of XIAP/Smac in gastric cancer

According to recent studies, Cannabidiol (CBD), one of the main components of Cannabis sativa , has anticancer effects in several cancers. However, the exact mechanism of CBD action is not currently understood. Here, CBD promoted cell death in gastric cancer. We suggest that CBD induced apoptosis by...

Full description

Saved in:
Bibliographic Details
Published in:Cell death & disease 2019-11, Vol.10 (11), p.846-13, Article 846
Main Authors: Jeong, Soyeon, Jo, Min Jee, Yun, Hye Kyeong, Kim, Dae Yeong, Kim, Bo Ram, Kim, Jung Lim, Park, Seong Hye, Na, Yoo Jin, Jeong, Yoon A, Kim, Bu Gyeom, Ashktorab, Hassan, Smoot, Duane T., Heo, Jun Young, Han, Jeongsu, Il Lee, Sun, Do Kim, Han, Kim, Dae Hyun, Oh, Sang Cheul, Lee, Dae-Hee
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:According to recent studies, Cannabidiol (CBD), one of the main components of Cannabis sativa , has anticancer effects in several cancers. However, the exact mechanism of CBD action is not currently understood. Here, CBD promoted cell death in gastric cancer. We suggest that CBD induced apoptosis by suppressing X-linked inhibitor apoptosis (XIAP), a member of the IAP protein family. CBD reduced XIAP protein levels while increasing ubiquitination of XIAP. The expression of Smac, a known inhibitor of XIAP, was found to be elevated during CBD treatment. Moreover, CBD treatment increased the interaction between XIAP and Smac by increasing Smac release from mitochondria to the cytosol. CBD has also been shown to affect mitochondrial dysfunction. Taken together, these results suggest that CBD may have potential as a new therapeutic target in gastric cancer.
ISSN:2041-4889
2041-4889
DOI:10.1038/s41419-019-2001-7